{"SPADE_UN_17687": {"Clinical Information": [], "Patent Information": [{"Patent No": "US8431396B2", "Patent Link": "http://www.lens.org/lens/patent/US8431396B2", "Patent Type": "Granted Patent", "Publication Date": "2013-4-30", "Family Info": "Notavailable", "Patent Title": "Anti-angiogenic peptides", "Abstract": "A purified polypeptide includes about 10 to about 40 amino acids and has an amino acid sequence corresponding to a portion of SEQ ID NO: 2. The polypeptide can inhibit binding of VEGF to VEGFR2 of cells that express VEGFR2."}], "Sequence Information": {"SPADE ID": "SPADE_UN_17687", "Sequence": "TRCPMIPCYI", "Sequence Length": 10, "Peptide Name": "Loop 5", "Source": "Synthetic", "Biological Activity": ["Antimicrobial", "Anticancer"], "Frequent Amino Acids": "CIP", "Absent Amino Acids": "ADEFGHKLNOQSUVW", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 5, "Positive Residues": 1, "Negative Residues": 0, "Mass": 1196.51, "PI": 7.73, "Net Charge": 1, "Hydrophobicity": 0.62, "Similar Sequences": [{"SPADE_ID": "SPADE_N_12004", "Similarity": 1.0, "Sequence": "RTCLTRC"}, {"SPADE_ID": "SPADE_N_12007", "Similarity": 1.0, "Sequence": "RTCFTRC"}, {"SPADE_ID": "SPADE_UN_17668", "Similarity": 1.0, "Sequence": "CKITRCPMIPCYISSPDECLWMDWVTEKNINGHQAKFFAC"}]}}}